Eloïse Laouenan: Rising Risk of Pregnancy Related Venous Thromboembolism
Eloïse Laouenan, PhD student in Life and Health Sciences at INSERM, midwife at CHU Brest, shared on LinkedIn about a recent article she and her colleagues co-authored, adding:
“New publication of our team about
Epidemiology of Pregnancy Related Venous Thromboembolism!!!
- 20,238 women included at delivery
- 6 maternity units
- 3-month postpartum follow-up
- Postpartum VTE incidence was 4.9 per 1,000 person-years, nearly twice higher than expected
- High VTE incidence after first week PP
- Postpartum thromboprophylaxis underprescribed
- High VTE incidence in intermediate-risk women regardless of thromboprophylaxis
MUM-VTE trial – NCT06845423 is recruiting in France to demonstrate the superiority of LMWH during 6 weeks VS no thromboprophylaxis in intermediate-risk women.
Special thanks to all pregnant women who advance research for women’s health.
Thanks to all the staff.”
Title: Epidemiology of venous thromboembolism during pregnancy and postpartum: results from the French prospective multicenter HEMOrrhage and venous THromboEmbolism in PostPartum study
Authors: Eloïse Laouenan, François Anouilh, Emmanuelle Courtois-Communier, Claire de Moreuil, Sara Robin, Ségolène Le Reun, Karine Morcel, Matthieu Jacquot, Violaine Bellec, Matthieu Muller, Christophe Tremouilhac, Nathalie Touffet, Caroline Cornec, Guillaume Drugmanne, Cécile Tromeur, Dominique Mottier, Karine Lacut , Raphaël Le Mao, Benjamin Espinasse, Gisèle Marhic, Emmanuelle Le Moigne
Read the Full Article on Journal of Thrombosis and Haemostasis.
Stay updated on all scientific advances with Hemostasis Today.
-
May 27, 2026, 09:58Omid Seidizadeh: Take The EAHAD Survey on Access to Diagnosis and Treatment for VWD Europe
-
May 27, 2026, 09:51Richard Benjamin: RedeS Phase III Trial Reaches Major Milestone in Advancing Pathogen-Reduced RBCs for Transfusion
-
May 27, 2026, 04:47Daniel Torrent: The Overlooked Epidemic of Post-Thrombotic Syndrome
-
May 27, 2026, 04:45Graziella Pompei: Is Aspirin Still a Valid Alternative to Clopidogrel in PCI with DES Implantation?
-
May 27, 2026, 04:40Kausik Ray: Phase 1 Trial Highlights Anti-Inflammatory Effects of Ruvonoflast
-
May 27, 2026, 04:29Francisco Chacón-Lozsán: High-Sensitivity Troponin and the Evolving Management of NSTEMI
-
May 27, 2026, 04:14Michael R. Jaff: HI-PEITHO Trial and NEWS Score Insights on Advances for Intermediate-Risk Pulmonary Embolism
-
May 26, 2026, 16:45Ashley George: Take the Leap for Thrombosis UK
-
May 26, 2026, 16:40Hamed Helisaz: Machine Learning for Detecting Missing Heart Medications